
Arsanis
closedAddressing critical infectious disease threats with targeted monoclonal antibody immunotherapies.
Employees
Enterprise value
$136m
Authorizing premium user...
Addressing critical infectious disease threats with targeted monoclonal antibody immunotherapies.